Pune-based pharma-packaging and clinical-trial-supplies group; parent holding company whose subsidiaries make PVC/PVDC blister films (Caprihans India) and run global clinical-trial supply-chain services (Bilcare GCS).
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 85 | 63 | 52 | 507 | 474 | 445 | 430 | 173 |
| Borrowings | 707 | 677 | 690 | 639 | 756 | 682 | 672 | 620 |
| Other Liabilities | 297 | 300 | 362 | 424 | 314 | 266 | 255 | 26 |
| Total Liabilities | 1.1k | 1.1k | 1.1k | 1.6k | 1.6k | 1.4k | 1.4k | 843 |
| AssetsFixed Assets | 534 | 494 | 465 | 1.0k | 1.0k | 949 | 930 | 433 |
| CWIP | 0 | 0 | 1 | 1 | 1 | 4 | 7 | 8 |
| Investments | 0 | 0 | 0 | 2 | 8 | 11 | 14 | 14 |
| Other Assets | 577 | 570 | 661 | 545 | 521 | 453 | 429 | 387 |
| Total Assets | 1.1k | 1.1k | 1.1k | 1.6k | 1.6k | 1.4k | 1.4k | 843 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 206 | 256 | 72 | 41 | -7 | 62 | 85 | 128 |
| Cash from Investing | -104 | 1.3k | 2 | -4 | 36 | -106 | 81 | -6 |
| Cash from Financing | -103 | -1.6k | -83 | -55 | -19 | 36 | -169 | -132 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 91 | 1.6k | 69 | 37 | 11 | -34 | 140 | 120 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
BI · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.